We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-17.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$47.7B
AUM Growth
-$12.1B
Cap. Flow
+$1.21B
Cap. Flow %
2.54%
Top 10 Hldgs %
20.23%
Holding
2,980
New
31
Increased
2,361
Reduced
322
Closed
49

Top Buys

Rank Stock Value
1
PLD icon
Prologis
PLD
+$22.7M
2
CNC icon
Centene
CNC
+$20M
3
IR icon
Ingersoll Rand
IR
+$18.4M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$16.8M
5
DLR icon
Digital Realty Trust
DLR
+$15.4M

Sector Composition

Rank Sector Weight
1 Technology 21.47%
2 Healthcare 14.79%
3 Financials 13.95%
4 Consumer Discretionary 9.78%
5 Communication Services 9.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBCP icon
2801
Concrete Pumping Holdings
BBCP
$491M
$86K ﹤0.01%
30,135
+15,429
+105% +$74.6K
LITS
2802
Lite Strategy Inc
LITS
$30.9M
$86K ﹤0.01%
2,680
SVRA icon
2803
Savara
SVRA
$1.19B
$86K ﹤0.01%
40,677
+1,101
+3% +$3.02K
AGS
2804
DELISTED
PlayAGS
AGS
$85K ﹤0.01%
31,907
SIEN
2805
DELISTED
Sientra, Inc.
SIEN
$85K ﹤0.01%
4,248
-342
-7% -$17.9K
BXG
2806
DELISTED
Bluegreen Vacations Corporation Common Stock
BXG
$85K ﹤0.01%
14,644
+3,320
+29% +$26.7K
CSLT
2807
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$84K ﹤0.01%
116,458
RJET
2808
Republic Airways Holdings
RJET
$1B
$83K ﹤0.01%
1,685
KALV
2809
DELISTED
KalVista Pharmaceuticals
KALV
$82K ﹤0.01%
10,727
-150
-1% -$2.02K
ZYNE
2810
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$82K ﹤0.01%
21,505
INWK
2811
DELISTED
InnerWorkings, Inc.
INWK
$82K ﹤0.01%
70,056
-782
-1% -$2.79K
MBII
2812
DELISTED
Marrone Bio Innovations, Inc.
MBII
$81K ﹤0.01%
99,270
+29,640
+43% +$31.4K
RMNI icon
2813
Rimini Street
RMNI
$471M
$80K ﹤0.01%
19,525
MBIO icon
2814
Mustang Bio
MBIO
$4.55M
$79K ﹤0.01%
39
AMR icon
2815
Alpha Metallurgical Resources
AMR
$1.93B
$78K ﹤0.01%
33,288
+4,200
+14% +$24.1K
SAN icon
2816
Banco Santander
SAN
$210B
$78K ﹤0.01%
34,808
+1,977
+6% +$6.78K
JAX
2817
DELISTED
J. Alexander's Holdings, Inc.
JAX
$78K ﹤0.01%
20,315
BXC icon
2818
BlueLinx
BXC
$706M
$77K ﹤0.01%
15,625
+1,310
+9% +$14.7K
FTK icon
2819
Flotek Industries
FTK
$1.28B
$77K ﹤0.01%
14,486
-4
-0% -$36
LEE icon
2820
Lee Enterprises
LEE
$182M
$77K ﹤0.01%
7,872
+2,069
+36% +$29.5K
ALDX icon
2821
Aldeyra Therapeutics
ALDX
$93.5M
$76K ﹤0.01%
30,784
EVLO
2822
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$76K ﹤0.01%
1,016
PRGX
2823
DELISTED
PRGX Global, Inc.
PRGX
$76K ﹤0.01%
27,012
SRT
2824
DELISTED
Startek Inc.
SRT
$75K ﹤0.01%
19,944
+844
+4% +$5.64K
SBBP
2825
DELISTED
Strongbridge Biopharma plc.
SBBP
$74K ﹤0.01%
38,917

Similar funds

RhumbLine Advisers's Q1 2020 Portfolio in Review

As of Q1 2020, RhumbLine Advisers held 2,980 positions worth $47.7B, down 20% from $59.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q1 2020: portfolio turnover was 2.7%. RhumbLine Advisers opened 31 new positions and exited 49, leaving the 2,980-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q1 2020 buy was PPD, Inc. Common Stock: 58,466 shares worth $1.04M.
  • RhumbLine Advisers added most to Prologis in Q1 2020, an estimated $22.7M increase.
  • RhumbLine Advisers's biggest Q1 2020 reduction was Apple, cutting an estimated $70.6M.
  • RhumbLine Advisers fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $34.9M.
  • RhumbLine Advisers's ten largest holdings make up 20% of its $47.7B portfolio in Q1 2020.
  • RhumbLine Advisers opened 31 new positions and closed 49 in Q1 2020.
  • RhumbLine Advisers's portfolio value fell 20% quarter-over-quarter to $47.7B.

Based on RhumbLine Advisers's 13F filing for Q1 2020, filed 6 May 2020.